AI Blood Assay Detects Liver Cancer Across Diverse International Populations
Researchers say the test identified 377 participants with greater sensitivity when paired with AFP and clinical risk factors.
8 Articles
8 Articles
AI-powered blood test detects liver cancer across distinct populations
Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.
Blood Test Boosts Early Detection of Liver Cancer
A blood test that analyzes genome-wide patterns of cell-free DNA (cfDNA) fragmentation detected hepatocellular carcinoma (HCC) more accurately than alpha-fetoprotein (AFP), the most widely used blood biomarker for liver cancer, according to a new study. The findings, published in Cell Press Blue from researchers at Johns Hopkins, suggest that combining cfDNA fragmentome analysis with AFP and clinical risk factors could improve early detection of…
AI blood assay detects liver cancer across diverse international populations
Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and uncovered the underlying biological signals that make the test effective.
AI Blood Test May Detect Liver Cancer Earlier
Detecting liver cancer early can save lives, but finding the disease before symptoms appear has always been difficult. Researchers at the Johns Hopkins Kimmel Cancer Center have now developed stronger evidence that an artificial intelligence-powered blood test could help doctors detect liver cancer earlier and more accurately. The study was published in Cell Press Blue. […] The post AI Blood Test May Detect Liver Cancer Earlier appeared first on…
AI blood test detects liver cancer across diverse global populations
Johns Hopkins researchers have validated an artificial intelligence-powered blood test that detected liver cancer in patients from two geographically and biologically distinct populations, while also identifying the biological signals that enable the test to recognize disease. The findings, published July 31 in Cell Press Blue, strengthen the case for genome-wide analysis of cell-free DNA as […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





